Amaryllis Nucleics, Inc.

RNA sequencing is vital for cutting-edge cancer diagnostics, pharmaceutical development, and food security, but the time and cost are major bottlenecks. At Amaryllis Nucleics, our technology breaks down these barriers by cutting time and cost manyfold – empowering researchers and accelerating important discoveries in genomics.

REQUEST INTRODUCTION USING

LINKEDIN ANGELLIST

COMPANY PEOPLE

Mike Covington

Mike Covington
Co Founder at Amaryllis Nucleics

Brad Townsley

Brad Townsley
CEO, Co-Founder at Amaryllis Nucleics

YOU MIGHT ALSO BE INTERESTED IN